Showing 6,049 results

Filters Content type: News, Editors' picks, About HIV Topic: HIV treatment

Treatment is recommended for all people living with HIV. It involves taking a combination of antiretroviral drugs. This stops the virus from replicating and allows the immune system to strengthen and fight infections.

PrEP science

The ‘long tail’ problem: injected-PrEP trial will be extended due to persistence of drug in companion study

News
11 November 2016
Changing treatment

Tenofovir alafenamide works well and improves kidney and bone markers in older people living with HIV

News
10 November 2016
Pharmaceutical industry

‘Hard’ Brexit would delay access to new drugs, warns report

Editor's pick
Pharma Times
9 November 2016
Smoking

Smoking more harmful than HIV for people taking effective treatment, US study suggests

News
8 November 2016
Treatment for women

Dolutegravir regimen highly effective in clinical trial for women

News
7 November 2016
New & experimental HIV treatments

Ibalizumab monoclonal antibody looks promising for people with drug-resistant HIV

News
4 November 2016
Treatment simplification strategies

Four days on, three days off HIV treatment controls viral load in French pilot study

News
3 November 2016
Pharmaceutical industry

GSK discontinues development of maturation inhibitor BMS-986173

Editor's pick
HIV i-Base
31 October 2016
Side effects

Efavirenz Side Effects Include Suicide; It Could Have Been Me

Editor's pick
The Body
31 October 2016
Treatment simplification strategies

Darunavir/ritonavir & lamivudine matches triple-drug therapy

News
31 October 2016
New & experimental HIV treatments

New long-acting fusion inhibitor albuvirtide plus boosted protease inibitor matches standard triple-drug therapy

News
28 October 2016
PrEP science

Tests of online PrEP purchases by London clinic find no fakes, and adequate drug levels

News
26 October 2016
PrEP

Two Thirds of Oral PrEP-Using MSM Would Switch to Long-Term Shots

Editor's pick
NATAP
26 October 2016
PrEP

More Surprises From ÉCLAIR: Cabotegravir's 'Long Tail'

Editor's pick
Medscape (requires free registration)
26 October 2016
Weight gain & lipodystrophy

The benefit of treatment has outweighed the clinical impact of lipodystrophy, conference hears

News
26 October 2016
Side effects

Dolutegravir and central nervous system side-effects: abacavir, older age increase the risk

News
25 October 2016
Changing treatment

Two-drug HIV therapy just as effective as three-drug therapy

News
25 October 2016
New & experimental HIV treatments

New nanomedicine approach aims to improve HIV drug therapies

Editor's pick
Science Daily
24 October 2016
News about aidsmap

Launch of About HIV / Pro VICH website

News
23 October 2016
Vaginal rings & topical PrEP

Rings, films or inserts? Researchers need to develop prevention products that make sense in women’s lives

News
21 October 2016
PrEP science

Second case report of PrEP failure due to drug-resistant virus

News
18 October 2016
The search for a cure

Crohn’s disease drug produces long-lasting viral undetectability and T-cell restoration off treatment in monkeys

News
14 October 2016
Side effects

Doctors in Netherlands observe higher than expected dolutegravir treatment discontinuation rate

News
13 October 2016
Adherence

Less than 100% adherence to HIV therapy, even with viral suppression, can lead to more inflammation and immune activation

News
12 October 2016